A Study of the Effects of Sodium Citrate on Olfactory Thresholds
NCT00409812 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2007-01-19
Summary
The study will be undertaken at the ENT department of the Leicester Royal Infirmary and in a research laboratory at the University of Leicester and also in the ENT department at the West Suffolk Hospital. One hundred subjects will be recruited. Subjects will be invited to undergo a series of smell tests using graded concentrations of 4 odours in 120ml bottles (1). This test has been described and validated by our previous work (2). The test will be fully explained to the subject beforehand by the researcher who will test the patient. The subject will be started with the smallest concentration of each odour and will ascend through the bottles until they detect 2 in a row, at which point the weaker concentration of the odour will be taken as their threshold. They will have a threshold levels determined for the odours phenethyl alcohol (roses), mercaptan (gas), acetic acid (vinegar) and eucalyptol (menthol).
Then, the subject will undergo a sodium citrate nasal douche at a specific concentration or will douche with sterile water. There will be three concentrations used (3%, 6% and 9%) and a control solution (sterile water). Patients will be randomly allocated to one of the four groups using a coded bottle system. Both patient and tester will be blinded to the solution used as these will be made in the pharmacy and coded for anonymity - the code will be broken at the end of the trial. Subjects will then be retested with the bottles and threshold levels will be observed for the four odours at 15 minute intervals over 2 hours. The purpose of the repeated tests is to determine the length of the effect (if present) of the citrate on the olfactory ability of the patients.
(N.B. Sodium citrate is a licensed product for use in body cavities (e.g. stomach, bladder) and can be found in the British National Formulary - the concentrations proposed do not exceed those used elsewhere.)
1. Wudarski TJ, Doty RL. Comparison of detection threshold values determined using glass sniff bottles and plastic squeeze bottles.Percept Mot Skills. 2004 Feb;98(1):192-6
2. Gaskin J, Robinson A, Philpott CM, Goodenough P, Murty G. Are patients cross-sensitive to odours in parallel threshold tests? Chemical Senses 2006; in progress
Conditions
- Anosmic and Hyposmic Patients
Sponsors & Collaborators
-
University Hospitals, Leicester
lead OTHER
Principal Investigators
-
Julian Gaskin, MBChB MRCSEd · University Hospitals, Leicester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
More Related Trials
-
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
NCT00170937 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
NCT01033071 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
NCT01256411 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012
NCT04035538 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension
NCT01599104 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
NCT00759551 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
NCT01456169 ·Status: COMPLETED ·Phase: PHASE3
-
Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers
NCT01353508 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4
-
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
NCT00383929 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
NCT00796159 ·Status: COMPLETED
-
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
NCT01012479 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
NCT05571813 ·Status: COMPLETED ·Phase: PHASE1
-
Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet
NCT00518765 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients
NCT00219193 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study
NCT01235377 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension
NCT00867490 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
NCT00699192 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
NCT00241072 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
NCT00241124 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
NCT00591773 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
NCT00846365 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension
NCT02184858 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.
NCT00696436 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
NCT00108706 ·Status: UNKNOWN ·Phase: PHASE4